Urine Mirrors Bladder Tissue Microbiome in Cancer Patients, Shotgun Study Finds

For years, scientists have suspected that the microbes living in urine might tell us something about the microbial communities dwelling on the bladder wall itself. The idea is intuitive: urine bathes the bladder lining continuously, so whatever bacteria it carries should, in theory, mirror the tissue-resident microbiota. But proving that link has been surprisingly difficult, because most earlier studies relied on 16S rRNA gene sequencing, a technique that reads only a single marker gene and cannot resolve microbes to the species level, and because voided urine samples are notoriously vulnerable to contamination from the skin and lower genital tract. A new study published in BMC Medicine by Kyungchan Min, Chuang-Ming Zheng, Yanghyun Joo and colleagues tackles both problems head-on, using sterile catheterized urine collection and full shotgun metagenomic sequencing to ask a deceptively simple question: does urine really reflect the bladder tissue microbiome in patients with bladder cancer?

The answer, at broad taxonomic levels, appears to be yes. The research team collected matched samples from patients undergoing treatment for bladder cancer under strictly sterile conditions, obtaining 79 bladder tissue specimens and 79 catheterized urine specimens, along with 17 rectal-swab stool samples from a subset of the same patients. Rather than the older 16S approach, the researchers deployed shotgun metagenomic sequencing, which reads all of the genetic material in a sample and can identify microbes at species-level resolution while also revealing the functional genes they carry. This matters because knowing which organisms are present is only half the story; the other half is understanding what metabolic pathways those organisms might be executing, information that species-level resolution makes possible to infer.

To analyze the data rigorously, the team divided patients into two groups based on specimen availability. The M-TUS group comprised 17 patients from whom tissue, urine, and stool were all available, while the larger M-TU group of 62 patients contributed matched tissue and urine only. The researchers then compared the three sample types using a battery of standard microbiome metrics. Alpha diversity measures, which capture the richness and evenness of species within each sample, showed that tissue and urine microbiomes were broadly similar to one another in both respects. When the team turned to beta diversity, assessed through Bray-Curtis dissimilarity, a metric that quantifies how different two microbial communities are in composition, the pattern was clear: tissue and urine samples were more similar to each other than either was to stool, which emerged as biologically distinct from the other two compartments.

That distinction is important for interpreting the growing literature on microbiomes and cancer. Stool samples are far easier to collect than tissue biopsies, and many studies have used gut microbiota as a convenient window into the body’s microbial state. But this study demonstrates that the gut community does not stand in for the bladder community. Species-sharing analysis reinforced the point, showing that tissue and urine samples shared more of their microbial species with each other than either shared with stool. The researchers extended the comparison to function as well, using metagenomically inferred metabolic pathways to ask whether the predicted functional potential of the tissue and urine communities converged. It did: predicted functional pathway concordance further supported the tissue-urine relationship and underscored the biological separateness of the gut compartment.

The team also probed whether microbial profiles differed by patient characteristics, specifically sex and tumor invasion status, which distinguishes non-muscle-invasive bladder cancer from the more aggressive muscle-invasive form. Class- and genus-level profiles were broadly similar between the sexes, and the differences between invasion groups were minimal. One apparent association between urine microbiota and sex did surface in the PERMANOVA statistical test, a permutational multivariate method widely used in microbiome research. However, the accompanying PERMDISP analysis, which tests whether groups differ simply in the spread of their samples rather than in their composition, revealed significant dispersion heterogeneity. The authors therefore interpreted the sex-associated result cautiously, a methodologically sound decision that reflects a common pitfall in microbiome statistics, where differences in within-group variability can masquerade as genuine compositional differences between groups.

Perhaps the most ambitious part of the study was an attempt to build a predictive model: could the team take a urine sample and computationally reconstruct the microbial profile of the corresponding bladder tissue? The researchers used ridge regression, a regularized linear modeling technique well suited to high-dimensional biological data, combined with principal component analysis to reduce dimensionality before fitting. The model was trained on the larger M-TU cohort and then tested on the independent M-TUS cohort, providing a genuine held-out validation. The results were strikingly level-dependent. At the phylum level, the model achieved an R-squared of 0.907 on the test set, meaning it explained over ninety percent of the variance in tissue microbial relative abundances from urine data alone. At the class level, performance remained strong with an R-squared of 0.834.

But the predictive power eroded as the taxonomic resolution sharpened. At the family and genus levels, the ridge regression model failed to outperform a null model, indicating that urine cannot yet reliably predict which specific families or genera populate the bladder tissue. This gradient makes biological sense: broad taxonomic categories capture the dominant structural features of a community, which are more likely to be shared between the urine and the tissue it contacts, whereas finer-grained composition may be shaped by local microenvironments on the bladder wall, differential shedding rates, and subtle sampling effects that a urine specimen cannot fully capture. The authors are candid about this limitation, noting that fine-resolution prediction will require validation in larger, multi-institutional, multi-ethnic cohorts that also include healthy controls, which the current cancer-only design lacked.

The practical implications are nonetheless considerable. Bladder cancer is one of the most common malignancies worldwide, and patients typically face lifelong surveillance because of the disease’s high recurrence rate. Current monitoring relies on cystoscopy, an invasive procedure, and urine-based biomarkers such as nuclear matrix protein 22, none of which capture microbial information. If catheterized urine can serve as a faithful proxy for tissue microbiota at broad taxonomic levels, as this study supports, it opens the door to less invasive microbiome profiling and, crucially, to longitudinal monitoring. A clinician could track a patient’s bladder microbial community over time through repeated urine collections, watching for shifts that might accompany recurrence, progression, or response to intravesical therapies, without ever touching the bladder wall with a scope.

The study also carries a methodological message for the field. By combining sterile catheterized collection with shotgun metagenomics, the researchers sidestepped the two biggest confounders of earlier urinary microbiome work: contamination from adjacent anatomical sites and the coarse resolution of 16S amplicon sequencing. The demonstration that stool is compositionally and functionally distinct from both urine and bladder tissue serves as a caution against extrapolating gut microbiome findings to urological contexts. At the same time, the honest reporting of where the predictive model broke down, at family and genus levels, illustrates the kind of transparency that builds trust in microbiome science. The work was supported by the National Research Foundation of Korea and other Korean funding bodies, with samples prepared through the National Biobank of Korea at Chungbuk National University Hospital, and it stands as a careful, technically rigorous step toward making the urinary microbiome a usable clinical instrument rather than an intriguing curiosity.

Subject of Research: Comparative microbiota analysis of urine, bladder tissue, and stool in bladder cancer using shotgun metagenomics

Article Title: Comparative analysis of urinary, bladder tissue, and stool microbiota in bladder cancer using shotgun metagenomics

Article References: Comparative analysis of urinary, bladder tissue, and stool microbiota in bladder cancer using shotgun metagenomics. (n.d.). https://doi.org/10.1186/s12916-026-05164-5

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05164-5

Keywords: bladder cancer, microbiome, microbiota, shotgun metagenomics, urine, bladder tissue, stool, ridge regression, Bray-Curtis dissimilarity, biomarker, PERMANOVA, BMC Medicine